Ensysce Biosciences (ENSC) Misses Q4 EPS by 75c
Tweet
Share
E-mailGet Alerts ENSC Hot Sheet
Join SI Premium – FREE
Ensysce Biosciences (NASDAQ: ENSC) reported Q4 EPS of ($0.75).
For earnings history and earnings-related data on Ensysce Biosciences (ENSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
- JPMorgan Upgrades FOX Corp. (FOXA) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
